Announcements

2 April 2025
MDPI INSIGHTS: The CEO's Letter #21 - Annual Report, Swiss Consortium, IWD, ICARS, Serbia

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Releases 2024 Annual Achievements Report

I’m pleased to share the release of MDPI’s 2024 Annual Achievements Report, which reflects our commitment to efficiency, transparency, and excellence in scholarly communication. The report showcases key themes related to our growth (highlighting our workforce expansion, new offices, journal milestones), excellence (editorial and publishing advancements), people (talent development and training), and community (partnerships, conferences, and outreach).

MDPI continues to build connections and drive scientific progress

Our mission remains clear: to support researchers worldwide by delivering an efficient, high-quality publishing experience while strengthening the global Open Access (OA) movement.

Advancing Open Access: A Global Knowledge Hub

In 2024, we published 238,000 peer-reviewed OA articles, reaching over 25 million downloads. This reinforces MDPI’s role as a global knowledge hub, breaking down barriers to access and ensuring that high-quality research is freely available to everyone. As part of the OA movement, we are actively democratizing knowledge, making scientific advancements accessible to researchers, policymakers, educators, and the public, without the restrictions of traditional paywalls.

Expanding our Workforce and Strengthening Research Integrity

Our global presence grew in 2024 with the opening of a new Seoul office, and our workforce expanded to 6,650 staff across 21 offices. This reflects our continued growth mindset and investment in global accessibility. We also continued to take a proactive stance on our commitment to research integrity, tripling our team in this area and joining STM’s Integrity Hub and United2Act. This means more rigorous quality control, stronger safeguards, and collaboration with global initiatives to detect and combat unethical publishing practices at an industry level. Our growth is about reinforcing our role as a trusted, ethical, and accessible publishing platform for researchers worldwide.

Growing Partnerships and Impact in Scholarly Communication

MDPI’s partnerships continue to thrive, with over 900 institutional collaborations, including a landmark agreement with ZB MED in Germany, covering more than 100 universities. Additionally, more than 90% of evaluated MDPI journals have been accepted into Web of Science, including 60 new acceptances in 2024, with nearly 300 journals expected to receive a Journal Impact Factor in 2025. In the same period, 37 MDPI journals were accepted into Scopus, bringing our total indexed titles to 306. Most importantly, 95% of authors rate their experience with MDPI as excellent or good – an achievement that underscores our dedication to serving the research community.

I encourage you to read through our Annual Report, which highlights these milestones and our vision for the future. Thank you for being part of MDPI’s journey in advancing open science.

Impactful Research

MDPI Renews Partnership with CSAL to Support Swiss Universities

I am pleased to announce the renewal of our partnership with the Consortium of Swiss Academic Libraries (CSAL) for 2025. This extension reinforces MDPI's dedication to advancing open science through transparency, efficiency, and collaboration.

Our renewed agreement with CSAL strengthens support for Swiss universities, ensuring that gold open access publishing remains both accessible and affordable for researchers across Switzerland. Among the institutions participating in this agreement are ETH Zurich and EPFL Lausanne, along with 20 other leading institutions, further expanding the reach and impact of our collaborative efforts.

To date, over 3.9 million researchers have published their findings in MDPI journals, a testament to our role in enhancing Switzerland's position as a hub for university education and research.

Inside MDPI

Celebrating International Women's Day: Accelerating Action

In honour of International Women's Day, MDPI embraced the theme “Accelerate Action,” a global call to advance women's progress by implementing effective strategies and resources. As part of our commitment, we highlighted how open access publishing empowers female voices in research and academia.

Throughout March, we featured original blogs authored by MDPI’s female contributors, showcasing the successes of our journals and employees, and addressing pressing topics such as women's health.

“Open Access supports women in education”

Women Accelerating Action Outside of MDPI

MDPI employee Ana Zdravkovic is accelerating action outside of her MDPI role as a Production Assistant. Working with like-minded women at the award-winning Belgrade-based organization UZOR OsnaŽene (meaning ‘empowered women’), they identify serious flaws in cybersecurity, and help protect women and children against online predators by providing evidence to improve legislation and laws around cyber-attacks.

In this article, we interview Ana, celebrating the important and inspiring work that she and the organisation do.

How Open Access Supports Women in Education

Every day, women and girls face barriers in education or career progression. This is caused by a range of factors, including social expectations, poverty, and poor infrastructure.

Quality opportunities and participation in the education system by women is essential to achieving equality and fulfilling their human rights.

Here, we examine how Open Access supports women in education by removing barriers and ensuring that vital research is accessible.

Recent Advancements in Research on Endometriosis

March is Endometriosis Action Month. Endometriosis is a medical condition affecting women and young girls of reproductive age, often causing symptoms such as severe pelvic pain, irregular periods, and infertility.

More research on endometriosis is still urgently needed.

This research will help develop efficient diagnoses and better treatment for those struggling with the condition.

In this article, we explore what endometriosis is and discuss the latest research advancements on the disease.

We also curated a selection of MDPI journals, articles, and Special Issues focusing on gender equity, women in the workplace, and women’s health.​ Find out more about these by visiting our IWD – Accelerate Action landing page.

As I reflect on the month of March and International Women’s Day, I would like to take a moment to recognize and thank all of the incredible women at MDPI for your dedication to democratizing knowledge and shaping open access. Your contributions are invaluable, and they continue to shape the future of MDPI.

Coming Together for Science

The International Conference on Advanced Remote Sensing (ICARS 2025)

The International Conference on Advanced Remote Sensing (ICARS 2025) took place from 26–28 March 2025, in Barcelona, Spain. It was chaired by Prof. Dr. Fabio Tosti from the Faringdon Research Centre for Non-Destructive Testing and Remote Sensing (UK), Prof. Dr. Andrea Benedetto from University Roma Tre (Italy), and Prof. Dr. Luis Ángel Ruiz from Universitat Politècnica de València (UPV, Spain).

Over three days, the conference explored innovations in Earth and environmental sciences, engineering advancements, and practical applications in biological and agricultural fields.

I am pleased to share that the 1st edition of ICARS 2025 was a great success, with 133 attendees out of 146 registrations. The event featured 43 short talks, 64 posters, and 103 accepted abstracts, along with nine keynote speakers and a major panel with five expert panellists.

Over 60 attendees joined the conference dinner, and the event received outstanding feedback.

The main goal of ICARS2025 was to cover how advanced remote sensing technologies are transforming our approach to global challenges.

Awards

Four awards were presented at the conclusion of the conference, sponsored by the journal Remote Sensing: Best Poster Award (€400), Best Oral Presentation Award (€400), and two Early Career Researcher Awards (1st prize: €600 and 2nd prize: €200).

Thank you to our Partnering Societies

We are grateful for the support of our four partnering societies and nine media partners, who played an important role in promoting the conference. Special thanks to our partnering societies: the European Federation of Geologists (EFG), Geoscience Energy Society of Great Britain (GESGB), Asociación Española de Teledetección (AET) – the Spanish Association of Remote Sensing, and the International Society for Digital Earth (ISDE).

Upcoming In-Person Event

31 March–2 April 2025
Plants 2025: From Seeds to Food Security
Location: Barcelona, Spain

This event will gather plant scientists to discuss the latest research on how to feed a growing population while maintaining a sustainable agro-ecosystem.

Find more upcoming MDPI events here.

Closing Thoughts

MDPI Serbia Salon 2025: A Gathering of Academic Excellence

On Tuesday, 18 March, we successfully concluded our first MDPI Serbia Salon in Belgrade. This event provided a great opportunity to showcase MDPI’s achievements, strengthen connections with the Serbian academic community, and highlight our role as the largest publisher in Serbia. We were honoured to welcome Prof. Dr. Sergej M. Ostojić, Editor-in-Chief of MDPI journal Clinical Bioenergetics, as a guest speaker.

Over the past five years, MDPI has experienced continuous growth in Serbia, with an increasing number of publications, an expansion of Editorial Board memberships, and a greater number of active peer reviewers. The Salon allowed us to express our thanks to the Serbian research community while gathering feedback from attendees representing several major universities.

Discussion topics

As part of the event, I delivered an opening speech highlighting MDPI’s achievements and direction.

The event featured presentations from MDPI colleagues, including discussions on open science, publishing ethics, and our achievements in Serbia.

A special thank-you to all our MDPI presenters, panellists, and organizers who made his event a success. I hope the MDPI Serbia Salon becomes a tradition for years to come, creating connections within the Serbian research community.

Visit to the Science Fund of Serbia and The Ministry of Science

During my visit to Belgrade, I had the opportunity to join my colleagues Emir Ramadani (Operations Manager) and Nevena Blagojev (Journal Relations Manager) in meetings with the Science Fund of Serbia and the Ministry of Science, where we received strong support for our work in Serbia.

Both organizations highly value our presence in and commitment to Serbia, where we employ over 640 staff across our two offices in Belgrade and Novi Sad. We take great pride in creating job opportunities and supporting the community in Serbia.

“There’s a lot of exciting activity happening in MDPI Serbia”

Speaking with our Serbian Colleagues

Finally, I had the opportunity to speak with our Serbian colleagues about our initiatives to expand and to improve our marketing & communication and public relations activities.

It was great to have an open discussion with colleagues – both in person and with the hundreds who joined online.

This visit to Belgrade had been a long time coming for me. Serbia is our largest operation in Europe and there’s a lot of exciting activity happening in MDPI Serbia, including the launch of a new office floor in Novi Sad and the growth and expansion of our teams.

I look forward to returning soon and continuing to support our colleagues across our Serbian offices.

Stefan Tochev
Chief Executive Officer
MDPI AG

27 February 2025
Rare Disease Day, 28 February 2025


28 February 2025 is the 18th International Rare Disease Day. The establishment of this international day aims to further increase the public’s attention and awareness of rare diseases, promote the popularization of rare diseases, promote the screening, diagnosis and prevention of rare genetic diseases, and improve the quality of life.

Rare diseases usually refer to diseases with a very low incidence rate. The World Health Organization defines diseases with a prevalence rate between 0.065% and 0.1% of the total population as rare diseases. Rare diseases do not refer to a specific disease but constitute a general term for diseases with a low incidence rate that occur in various systems. Although the incidence rate of a single rare disease is low, there are many types, currently more than 7,000, and the total number of patients with rare disease is quite high. According to statistics, there are more than 300 million patients with rare diseases in the world. Rare diseases are mostly chronic and serious diseases that often endanger life.

In recognition of this day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine areas and society areas. We believe that sharing such research can raise the public’s awareness and understanding of rare diseases. By disseminating these findings, we hope to inspire positive change, promote scientific education on rare diseases, and promote the screening, diagnosis and prevention of rare genetic diseases.

   

Evaluation of ACR TI-RADS for Predicting Malignancy in Thyroid Nodules: Insights from Fine-Needle Aspiration Cytology and Histopathology Results
by Ahmed Alsibani, Mohammed Alessa, Fahad Alwadi, Shams Alotaibi, Hana Alfaleh, Ali M. Moshibah, Abdullah M. Alqahtani, Abdulwahed AlQahtani, Mohammad Almayouf, Saleh F. Aldhahri et al.
J. Oman Med. Assoc. 2024, 1(1), 61-68; https://doi.org/10.3390/joma1010007

Endoscopic Guided Dilations without Intralesional Corticosteroid Injections: Pediatric Crohn’s Patients Case Series
by Leo Fawaz, Yousif Slim and Peter N. Freswick
Reports 2024, 7(4), 81; https://doi.org/10.3390/reports7040081

Self-Reported Medication Adherence Measured with Morisky Scales in Rare Disease Patients: A Systematic Review and Meta-Analysis
by Ana María García-Muñoz, Desirée Victoria-Montesinos, Begoña Cerdá, Pura Ballester, Eloisa María de Velasco and Pilar Zafrilla
Healthcare 2023, 11(11), 1609; https://doi.org/10.3390/healthcare11111609

Epidermolysis Bullosa—A Kindler Syndrome Case Report and Short Literature Review
by Bogdan Ioan Stefanescu, Diana Sabina Radaschin, Geta Mitrea, Lucretia Anghel, Adrian Beznea, Georgiana Bianca Constantin and Alin Laurentiu Tatu
Clin. Pract. 2023, 13(4), 873-880; https://doi.org/10.3390/clinpract13040079

Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview
by Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, Giovanni De Biasi, Anna Colagrande, Katia Mangialardi, Francesco Gaudio and Giuseppe Ingravallo
Hematol. Rep. 2023, 15(4), 696-706; https://doi.org/10.3390/hematolrep15040070

Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network
by Jesse Fishman, Seth Kuranz, Michael M. Yeh, Kaylen Brzozowski and Herman Che
Hematol. Rep. 2023, 15(2), 266-282; https://doi.org/10.3390/hematolrep15020027

New-Generation Ektacytometry Study of Red Blood Cells in Different Hemoglobinopathies and Thalassemia
by Elena Krishnevskaya, Marta Molero, Águeda Ancochea, Ines Hernández and Joan-Lluis Vives-Corrons
Thalass. Rep. 2023, 13(1), 70-76; https://doi.org/10.3390/thalassrep13010007

Widespread and Long-Enduring Hyperkeratosis Lenticularis Perstans (Flegel’s Disease): Clinico-Pathological and Dermoscopic Features of a Rare Presentation
by Giorgio Stabile, Giovanni Paolino, Nathalie Rizzo and Franco Rongioletti
Dermatopathology 2023, 10(1), 46-51; https://doi.org/10.3390/dermatopathology10010006

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54-62; https://doi.org/10.3390/dermatopathology10010008

Repositioning Drugs for Rare Diseases Based on Biological Features and Computational Approaches
by Belén Otero-Carrasco, Lucía Prieto Santamaría, Esther Ugarte Carro, Juan Pedro Caraça-Valente Hernández and Alejandro Rodríguez-González
Healthcare 2022, 10(9), 1784; https://doi.org/10.3390/healthcare10091784

Innovative Therapies and Management of Complications in Hemoglobinopathies
Guest Editors: Dr. Sophia Delicou and Prof. Dr. Constantina Politis
Submission deadline: 31 May 2025

27 February 2025
More than 300 MDPI Journals Indexed in Web of Science

MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines. 

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data. 

This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide. 

As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.

17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards


MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.

Honoring Excellence in Research

The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:

Early Career Researcher (Postdoc) Award:

  • Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
  • Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
  • Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.

Early Career Researcher (Ph.D.) Award:

  • Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
  • Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
  • Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.

Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.

Looking Ahead to 2025

Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.

Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.

5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2024 Annual Meeting – Beijing (15 January 2025)

You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.

Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.

This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.

I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.

“Our editorial teams represent MDPI at its finest”

I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.

Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.

MDPI Offices in China

While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.

While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.

We look forward to a year filled with continued collaboration, growth, and shared success.

“We remain committed to future growth in China”

Impactful Research

MDPI and Jisc Consortium Extend Open Access Agreement for 2025

I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.

Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.

Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.

A full list of participating institutions can be found here.

As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”

At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.

Inside MDPI

Visit to MDPI's Singapore office

During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.

Welcoming and Supporting New Team Members

“Experienced staff play an important role in mentoring new hires”

I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.

Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.

Building MDPI’s Positive Reputation

During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.

Connecting with the Singapore Marketing Team

I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow. 

During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.

Meeting with Prof. Dr. Manoj Gupta

Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.

Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.

Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.

During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.

PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!

 

Coming Together for Science

JAMS – Journal & Article Management System

I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.

With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.

“JAMS is a testament to our commitment to simplifying the publishing process”

Explore the new website here: jams.pub

It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.

Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.

JAMS was built to change that by adapting to the unique requirements of each publisher.

At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.

Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.

Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

What Sets JAMS Apart?

  • Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
  • End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
  • Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
  • Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
  • Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.

Partners Who Already Trust JAMS

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

Closing Thoughts

Visit to MDPI's Bangkok office

To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.

I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.

Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.

Engaging with Group Leads

“Group leads play an important role in creating a safe, positive environment”

During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.

To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.

University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)

We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.

Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.

This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.

“My time in Bangkok was productive and inspiring”

My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 February 2025
World Cancer Day 2025—United in Every Journey


Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

Biology & Life Sciences

Medicine & Pharmacology

Chemistry & Material Sciences

Public Health & Healthcare

Engineering

Society

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

Biomarkers in Breast Cancer: An Old Story with a New End
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032

Comprehensive Treatment of Rectal Cancer

Mental Health and Nursing Care of Individuals with Cancer and Their Families—2nd Edition

New Advances in Community-Based Approaches to Cancer Prevention Epidemiology

Cancer Immunotherapy and the PD-1/PD-L1 Checkpoint Pathway

Novel, Low Cost Technologies for Cancer Diagnostics and Therapeutics

Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

Pulmonary Fibrosis and Lung Cancer: Pathophysiology and Novel Therapeutic Approaches

 

26 January 2025
World Neglected Tropical Diseases Day—30 January 2025


On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.

We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.

   

A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568

Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047

Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050

Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203

Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205

False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100

Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022

Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014

Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425

DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624

Global Fight against Malaria: Goals and Achievements 1900–2022
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680

Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469

Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128

Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285

Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015

Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658

Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition

Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases

Special Issue: “One Health and Neglected Zoonotic Diseases

Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota

26 January 2025
Meet Us at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery, 20–22 February 2025, Yamaguchi, Japan


Conference:
The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery
Date: 20–22 February 2025
Location:
Yamaguchi, Japan

MDPI will be attending the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery as an exhibitor which will be held from 20 to 22 February 2025. We invite researchers from different fields of study to share their ideas with us.

The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery will be held in Shimonoseki. The theme of the annual meeting is “Beyond The WAVE! Go on and overcome!”. This meeting theme aims to help surgeons overcome difficulties and challenges during their growth and development. The entire meeting will be split into five areas of coronary artery disease—valvulopathy, aortic disease, congenital malformations, and peripheral vascular disease—each of which has its own Program Committee that has put together the primary sessions. Attending the meeting is important for academic learning at the venue, but exchanging views with other participants, obtaining new information, and engaging in conversations is also extremely meaningful.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to visit booth #27 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. We warmly encourage researchers from different backgrounds to visit and share their ideas with us.

For more information about the conference, please visit the following website: https://www.congre.co.jp/jscvs2025/en/index.html.

22 January 2025
Meet Us at the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, 2 March 2025, Osaka, Japan


Conference: The 102nd Annual Meeting for the Osaka Society for Dialysis Therapy
Date: 2 March 2025
Location: Osaka, Japan

MDPI will be attending the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, which will be held on 2 March 2025, as an exhibitor, and we welcome researchers from various backgrounds to visit and share their latest ideas with us.

In the future, it is expected that the introduction of generative AI, IoT, and robotics will enhance medical services, expand and strengthen research support systems, and further improve medical technologies. The Osaka Dialysis Research Society has the mission of achieving sustainable development in the fields of dialysis and chronic kidney disease treatment, thereby improving the quality of life (QOL) and prognosis of patients undergoing dialysis and those with chronic kidney disease. To fulfill this mission, they aim to strive for the introduction of the latest research and technologies in dialysis therapy and chronic kidney disease treatment, as well as the education, professional development, and training of medical practitioners.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://osdt.jp/102th/.

22 January 2025
Acknowledgment to the Reviewers of Clinics and Practice in 2024


The editorial team at Clinics and Practice extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Clinics and Practice received 1231 review reports from 842 reviewers representing 74 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Clinics and Practice expresses its sincere gratitude through an annual acknowledgment of reviewers.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

Aayushi Manchanda Konstantinos Seretis
Abdulaziz Alhotan Kourosh Sheibani
Abel Lerma Ksenia Babina
Abhijit Nair Lassoued Zohra
Abiola Victor Adepoju Laura Stătescu
Ach Taieb Laura Zlibinaite
Adewale Bayode Owa Luca Galassi
Adina Oana Armencia Lucia Ansani
Adina Thomaidis Luigi Buongiorno
Adrián Mateo-Orcajada Luis Tallón-Aguilar
Agnieszka Dombrowska-Pali Maciej Jedliński
Agnieszka Wareńczak-Pawlicka Maciej Tysarkowski
Ahlam Badreldin El Shikieri Mahdi Saeedi Moghadam
Ahmed A. Khalifa Mahmoud M. A. Elsayed
Ahmed Elfana Makan Cheraghpour
Ahmed Mousa Mandeep Singh Rahi
Ahmet Can Topcu Marcel Alexandru Gaina
Alarico Ariani Marco Zeppieri
Alejandra Giselle Juárez-Rebollar Maria De Los Angeles Erario
Aleksandar Jakovljević Maria Loureiro
Alessandro Libretti Maria Rita Di Pace
Alexander Zimmermann María Teresa Hernández-Huerta
Alexandre Baudet Mariateresa Giglio
Alexandru Vlasa Mario Alberto Isiordia-Espinoza
Alexandru Catalin Motofelea Mario Fruschelli
Alexandru Dan Costache Marko Baralic
Alexey Sarapultsev Márton Zsoldos
Ali Alsaegh Masoud Keikha
Ali Kashkooe Mateusz Czajkowski
Alin-Constantin Pînzariu Mateusz Zamłyński
Aljaz Hojski Matilde Tettamanzi
Almerinda Agrelli Matteo Chiappedi
Alperen Degirmenci Matteo Pepa
Alvaro Perez Mederle Alexandru Ovidiu
Amany Elshenawy Mehmet Gökhan Demir
Amirmohammad Khalaji Menelaos Zafrakas
Amit Hudgi Meredith T. Yeung
Ana Luiza De Carvalho Felippini Merve Candan
Ana Teixeira Michael Pinkawa
Anas Rashid Michelangelo Luciani
Anastasios Serbis Miljana Z Jovandaric
András Molnár Mina Miroslavova Pencheva
André Eduardo Da Silva Júnior Mohammad Altamimi
Andre Luiz Ferreira Costa Mohammad Younis Hajeer
Andrea D'Arino Mohammed A. Mashali
Andrea Piasentin Mohammed Abdulrasak
Andrea Sonaglioni Mohammed Nahidh
Andrey Markov Muhammed Yunus Bektay
Andrius Bleizgys Murillo-Gómez Fabián
Ángel Becerra-Bolaños Myung-Chul Kim
Angelica Cersosimo Nadeem Ullah
Angelos K. Sikalidis Nader Tarabeih
Anichavezhi Devendran Nagla'A Abdel-Wahed
Anilkumar Thaghalli Shivanna Narongchai Autsavapromporn
Anna Rogozińska-Pawełczyk Natale Calomino
Anna-Mariia Shulhai Natalia Świątoniowska-Lonc
Anton R Kiselev Neha Mishra
Antonino Maniaci Neil Merrett
Antonio Ribelles-García Nicolas Cohn
Anupama Rani Nihat Mujdat Hokenek
Ao Zhang Nikolaus Thierfelder
Ariel Teles Nikoleta Bizymi
Aris Kaltsas Nora Hosny
Asaad Babker Nuha A El Sharif
Asmaa Fathi Hamouda Nuno José Rodrigues
Asokan Ramasamy Octavian Andronic
Azahara Fernandez-Carbonell Omar Hamdy
Bahar Ciftci Ozgur Karcioglu
Biagio Barone Paola Pentangelo
Bogdan Andrei Suciu Paolo Perini
Burcin Celik Paraschiva Chereches-Panta
Caleya Zambrano Antonia María Paschalis Karakasis
Carlo Biz Pedro Catalão Moura
Carlos Goicoechea Pepe Ludovica
Carlos López-De-Celis Petar Antonov
Ceren Durmaz Engin Petar Kalaydzhiev
Chiara Comisi Petar Ozretić
Chien-Liang Chen Phuc Nhon Nguyen
Chou-Yi Hsu Pingan Chang
Christian Saleh Plinio Cirillo
Christina Oetzmann Von Sochaczewski Pooja Mittal
Claire-Marie Rangon Prajakta P Masurkar
Claudio Bovolenta Murta Praveen Koganti
Coen Zandvoort Priyanka Prakash Desai
Collins Ogbeivor Rafal Studnicki
Cosmin Ioan Faur Rakesh Kumar
Cristina Bettencourt Neves Ramachandra Barik
Dalia Medhat Rebeca Boltes Cecatto
Dan Boitor-Borza Renu Khasa
Daniel J. Joseph Meara Ricardo Dias
Dimitri Kakabadse Ricardo Ruiz-Villaverde
Dimitrios N. Kanakis Rita Noites
Dirk W. Lachenmeier Rob Sillevis
Doha Mohamed Robert Konrad Szymczak
El Hafidi Naima Roberta Scrimieri
Eleni Moka Roberto Ariel Abeldaño Zuñiga
Elisa Belluzzi Rodolfo Reda
Elzbieta Kaczmarek Runbo Li
Emmanouil Karampinis Safaa Elmeneza
Emmanouil M. Xydias Saloua Mrabet
Enes Erul Salvatore Vaccaro
Enric I. Canela Sameh Abd El-Ghany
Enrique Cervantes-Pérez Samuel Álvarez-Almazán
Enrique Gea-Izquierdo Sandra Maria Campinos Rodrigues
Eren Yildiz Sanjin Kovacevic
Eugenio Velasco-Ortega Santosh Paudel
Evangelia Koukaki Sarhang Gul
Faiza Amin Sathish Thirunavukkarasu
Fazlı Yanık Saurabh Jain
Federica Pulicari Saurabh Rambiharilal Shrivastava
Filip Jaskiewicz Sebastian Valverde-Martinez
Fortunato Cassalia Sebastian Zduński
Francisco Villegas Lirola Serap Özer Yaman
Franco Alchiede Simonato Sergey A. Apryatin
Fredrik Brännström Sergio Serrada-Tejeda
Gabriela Lopes Gama Serkan Yílmaz
Gabriele Roccuzzo Shaoni Mukhopadhyay
Gabriella Trucco Shashank Shekhar
Georgios Iatrakis Shuchao Ge
Giorgio Sodero Simon Bernard Iloki Assanga
Giovanni Barassi Sinan Eğri
Giovanni Mazzucato Sirvan Najafi
Giuseppe Gullo Sivakumar Nuvvula
Gopinath M. Sundaram Smriti Aryal AC
Grigol Keshelava Snezana Pantovic
Guilherme Guimarães Sohier Yahia
Gulali Aktas Sophia Charitou
Gurpreet Singh Stefana Maria Moisa
Gustavo Bresky Sumedha Nitin Prabhu
Hamid Morovati Susanna Longo
Hasnaa Osama Syed Adeel Hasan
Hassan Mirzaei Sylwia Dziegielewska-Gesiak
Hatem Alhadainy Tabussam Tufail
Hayley Derricott Tahir Yusuf Noorani
Heyue Du Tarik Kivrak
Hiroko Ishiwata-Endo Teodor Florin Georgescu
Hiu Chuen Lok Timea Claudia Ghitea
Hossam El-Din Moustafa Tippawan Siritientong
Hülya Şimşek Tomislav Kokic
Husam Qanash Toshikazu Suzuki
Huseyin Anıl Korkmaz Uma Maheswari Deshetty
Huseyin Polat Vahid Karamzadeh
Ilaria Stura Valentin Nicolae Varlas
Ionut Luchian Vanessa Moby
Irini Patsaki Vasile Valeriu Lupu
Ivan Neil Gomez Vasiliki Michou
Ivan Tong Mak Veysel Umman
Ivana R. Babovic Viet Tran
Jacinta Pinho Vikash Agrawal
Jakir Hossain Bhuiyan Masud Vincenzo Calabrese
Javier Laguna Vladimir M. M. Cvetković
Jean De La Rosette Vlad-Ionut Nechita
Jean Pierre Enriquez Waleed Seif Eldin Mohamed
Jesus Oliva Pascual-Vaca William James Antonisamy
Jia Jiet Lim Xiaojian Tan
Jiawei Huo Xiaoyan Liu
Jie Liu Xingruo Zhang
Jing Li Xinye Chen
João José Joaquim Yaiza Taboada-Iglesias
Jochen Pfeifer Yana Korneeva
Jong-Hwa Jang Yasumori Sobue
José Antonio Guerrero-Solano Yi-Hung Chiang
José Carlos Vázquez-Parra Yina Wang
Julia María Alatorre-Cruz Yukun Zhang
Juliet Haarbauer-Krupa Yuning Chen
Junichi Saito Yuri Chaves Martins
Kakarla Ramakrishna Yuriy S. Bronshteyn
Kamal Sharma Yutaro Kuwahara
Kamil Koszela Zelia Gouveia
Karel Van Den Bosch Zenon Pogorelić
Kazuki Ide Zhekai Hu
Kenneth N. White Zhengwei Huang
Kinga Lis Zhiwei Yang
Kiran Upadhyay Zlatina Tomova
Koen Michael Reyntjens Zorica Cvetković
Konosuke Nakaji Zulkif Tanriverdi

Back to TopTop